2m 2m 2m 2m 2m 2m 2m
ENSYSCE BIO (ENSC)
NASDAQ
$0.27-$0.003 (-1.13%)
Price as of Jun 23, 2026 7:55 PM EDT- $4.2MMarket Cap
- -87.18%1-Year Change
- BiotechnologyIndustry
ENSYSCE BIO (ENSC)
$0.27-$0.003 (-1.13%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.1M -2.75% | 5.2M +133.58% | 2.2M -11.61% | 2.5M -28.54% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 5.1M -2.75% | 5.2M +133.58% | 2.2M -11.61% | 2.5M -28.54% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -10.4M +43.74% | -7.2M -4.85% | -7.6M -61.75% | -19.8M +322.93% | |
Depreciation and Amortization Expense | 6,533 N/A | 0 N/A | 0 N/A | N/A N/A | |
Total Operating Expenses | 15.3M +28.20% | 11.9M -7.79% | 12.9M -51.59% | 26.7M +14.29% | |
Operating Profit | -10.2M +52.17% | -6.7M -37.21% | -10.7M -55.75% | -24.2M +21.90% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -12,393 -99.03% | -1.3M +262.09% | -353,945 +223.16% | -109,525 -91.54% | |
Interest Income and Expense and Net | -12,393 -99.03% | -1.3M +262.09% | -353,945 +223.16% | -109,525 -91.54% | |
Total Nonoperating Income and Expense | 64,759 +105.15% | -1.3M -1,467.48% | 91,912 +537.83% | 14,410 +100.16% | |
Income before Taxes | -10.2M +27.40% | -8.0M -24.83% | -10.6M -57.64% | -25.1M -16.07% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -10.2M +27.40% | -8.0M -24.84% | -10.6M -56.10% | -24.2M -16.94% | |
Net Income from Continuing Operations Applicable to Common | -10.2M +27.40% | -8.0M -24.83% | -10.6M -57.64% | -25.1M -16.07% | |
Basic EPS and Net Income | -3.98 -65.24% | -11.45 +144.14% | -4.69 -59.64% | -11.62 +685.14% | |
Diluted EPS and Net Income | -3.98 -65.24% | -11.45 +144.14% | -4.69 -59.64% | -11.62 +685.14% | |
Basic Weighted Average Shares | 2.6M +266.55% | 697,686 -69.18% | 2.3M +4.86% | 2.2M -89.29% | |
Diluted Weighted Average Shares | 2.6M +266.55% | 697,686 -69.18% | 2.3M +4.86% | 2.2M -89.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.3M +23.08% | 3.5M +211.68% | 1.1M -64.30% | 3.1M -74.34% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.3M +23.08% | 3.5M +211.68% | 1.1M -64.30% | 3.1M -74.34% | |
Total Current Assets | 7.2M +35.51% | 5.3M +133.51% | 2.3M -56.81% | 5.3M -66.17% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 124,129 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 85,882 -65.99% | 252,550 -39.76% | 419,217 -28.45% | 585,883 -22.37% | |
Total Assets | 7.5M +33.15% | 5.6M +106.69% | 2.7M -53.98% | 5.9M -64.15% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 306,708 +1.67% | 301,660 -64.71% | 854,697 -79.97% | 4.3M -66.53% | |
Total Current Liabilities | 4.6M +106.95% | 2.2M -33.78% | 3.3M -64.78% | 9.5M -42.58% | |
Total Long-Term Debt | 242,761 -19.52% | 301,660 -94.85% | 5.9M +1,199.62% | 450,494 -96.56% | |
Total Long-Term Liabilities | N/A N/A | 10,096 -61.74% | 26,388 -94.14% | 450,494 -94.43% | |
Total Liabilities | 4.6M +106.00% | 2.2M -34.00% | 3.4M -66.12% | 9.9M -59.66% | |
Retained Earnings | -139.7M +7.85% | -129.5M +6.57% | -121.6M +9.58% | -110.9M +29.22% | |
Total Stockholders Equity | 3.2M -13.34% | 3.7M +1,248.62% | -322,858 -91.31% | -3.7M -52.85% | |
Total Shares Outstanding | 4.6M +237.44% | 1.4M -56.91% | 3.1M -50.95% | 6.4M -73.97% | |
Cash Flow | |||||
Cash from Operating Activities | -7.8M +4.05% | -7.5M -30.40% | -10.8M -39.73% | -17.9M +117.02% | |
Capital Expenditures | 123,643 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -123,643 N/A | N/A N/A | N/A N/A | 4,500 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.7M -11.57% | 9.9M +12.85% | 8.8M -0.11% | 8.8M -56.85% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -202.12% +56.47% | -129.18% -73.12% | -480.52% -49.94% | -959.91% +70.59% | |
Return on Assets | -155.95% -18.92% | -192.33% -22.23% | -247.32% +13.93% | -217.09% +9.01% | |
Return on Equity | -294.00% -37.69% | -471.83% -189.63% | 526.40% +26.04% | 417.64% -34.91% | |
Revenue Growth | -2.75% -102.06% | 133.58% +1,250.95% | -11.61% -59.33% | -28.54% N/A | |
Current Ratio | 1.59 -34.52% | 2.42 +252.63% | 0.69 +22.65% | 0.56 -41.08% | |
Cash Ratio | 0.94 -40.52% | 1.59 +370.69% | 0.34 +1.35% | 0.33 -55.30% | |
Debt-to-Equity Ratio | 0.17 +5.10% | 0.16 +100.78% | -20.78 +1,536.45% | -1.27 -61.29% | |
Debt-to-Assets Ratio | 0.07 -31.63% | 0.11 -95.65% | 2.48 +209.11% | 0.80 -49.08% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow